These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 29508268)

  • 1. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
    Bustos Fernández LM; Man F; Lasa JS
    Dig Dis; 2023; 41(5):798-809. PubMed ID: 36630947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
    Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
    Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
    Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
    [No Abstract]   [Full Text] [Related]  

  • 6. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Ghoshal UC; Shukla R; Ghoshal U
    Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
    Reddymasu SC; Sostarich S; McCallum RW
    BMC Gastroenterol; 2010 Feb; 10():23. PubMed ID: 20175924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    Bixquert Jiménez M
    Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
    Jung SE; Joo NS; Han KS; Kim KN
    J Korean Med Sci; 2017 Jun; 32(6):948-953. PubMed ID: 28480652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan.
    Yakoob J; Abbas Z; Khan R; Hamid S; Awan S; Jafri W
    Saudi J Gastroenterol; 2011; 17(6):371-5. PubMed ID: 22064333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
    Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
    Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases].
    Madrid AM; Defilippi C C; Defilippi G C; Slimming A J; Quera P R
    Rev Med Chil; 2007 Oct; 135(10):1245-52. PubMed ID: 18180830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress.
    Grover M; Kanazawa M; Palsson OS; Chitkara DK; Gangarosa LM; Drossman DA; Whitehead WE
    Neurogastroenterol Motil; 2008 Sep; 20(9):998-1008. PubMed ID: 18482250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.